Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163521 | SCV000214079 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000199434 | SCV000252939 | likely benign | Familial adenomatous polyposis 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704030 | SCV000293586 | likely benign | not provided | 2021-06-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24728327, 26530882, 28135048, 28195569, 28873162, 25479140) |
Color Diagnostics, |
RCV000163521 | SCV000681920 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-10 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000199434 | SCV000784916 | uncertain significance | Familial adenomatous polyposis 1 | 2017-02-08 | criteria provided, single submitter | clinical testing | |
Ai |
RCV001704030 | SCV002503285 | uncertain significance | not provided | 2020-05-07 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000120047 | SCV002773890 | benign | not specified | 2021-07-28 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000199434 | SCV004018766 | likely benign | Familial adenomatous polyposis 1 | 2023-02-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
ITMI | RCV000120047 | SCV000084181 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
3DMed Clinical Laboratory Inc | RCV000677785 | SCV000803941 | uncertain significance | Neoplasm of the liver | 2018-05-21 | no assertion criteria provided | clinical testing | |
3DMed Clinical Laboratory Inc | RCV000677786 | SCV000803942 | uncertain significance | Hepatocellular carcinoma | 2018-05-21 | no assertion criteria provided | clinical testing | |
3DMed Clinical Laboratory Inc | RCV000677787 | SCV000803943 | uncertain significance | Intrahepatic cholangiocarcinoma | 2018-05-21 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003952585 | SCV004768397 | likely benign | APC-related disorder | 2020-03-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |